SRC and glioblastoma: Importantly, Src kinase activity is often aberrantly upregulated in glioblastoma downstream mutations that upregulate EGFR (Epidermal Growth Factor Receptor) or other receptor tyrosine kinases which in turn may drive the constitutive activation of Src; indeed Src has been identified as a potential target for glioblastoma therapy [68].